Pharmacological profile of CS-3150, a novel, highly potent and selective non-steroidal mineralocorticoid receptor antagonist
Arai, Kiyoshi, Homma, Tsuyoshi, Morikawa, Yuka, Ubukata, Naoko, Tsuruoka, Hiyoyuki, Aoki, Kazumasa, Ishikawa, Hirokazu, Mizuno, Makoto, Sada, Toshio
Published in European journal of pharmacology (15.08.2015)
Published in European journal of pharmacology (15.08.2015)
Get full text
Journal Article
The functional Hfq-binding module of bacterial sRNAs consists of a double or single hairpin preceded by a U-rich sequence and followed by a 3' poly(U) tail
Ishikawa, Hirokazu, Otaka, Hironori, Maki, Kimika, Morita, Teppei, Aiba, Hiroji
Published in RNA (Cambridge) (01.05.2012)
Published in RNA (Cambridge) (01.05.2012)
Get full text
Journal Article
Patritumab deruxtecan (HER3-DXd), a novel HER3 directed antibody drug conjugate, exhibits in vitro activity against breast cancer cells expressing HER3 mutations with and without HER2 overexpression
Koyama, Kumiko, Ishikawa, Hirokazu, Abe, Manabu, Shiose, Yoshinobu, Ueno, Suguru, Qiu, Yang, Nakamaru, Kenji, Murakami, Masato
Published in PloS one (03.05.2022)
Published in PloS one (03.05.2022)
Get full text
Journal Article
Direct and quantitative analysis of altered metabolic flux distributions and cellular ATP production pathway in fumarate hydratase-diminished cells
Noguchi, Shingo, Ishikawa, Hirokazu, Wakita, Kenichi, Matsuda, Fumio, Shimizu, Hiroshi
Published in Scientific reports (03.08.2020)
Published in Scientific reports (03.08.2020)
Get full text
Journal Article
Neuroprotection and axon regeneration by novel low-molecular-weight compounds through the modification of DOCK3 conformation
Namekata, Kazuhiko, Tsuji, Naoki, Guo, Xiaoli, Nishijima, Euido, Honda, Sari, Kitamura, Yuta, Yamasaki, Atsushi, Kishida, Masamichi, Takeyama, Jun, Ishikawa, Hirokazu, Shinozaki, Youichi, Kimura, Atsuko, Harada, Chikako, Harada, Takayuki
Published in Cell death discovery (15.05.2023)
Published in Cell death discovery (15.05.2023)
Get full text
Journal Article
An angiotensin II type 1 receptor antagonist, olmesartan medoxomil, improves experimental liver fibrosis by suppression of proliferation and collagen synthesis in activated hepatic stellate cells
Kurikawa, Nobuya, Suga, Miwa, Kuroda, Shoko, Yamada, Keisuke, Ishikawa, Hirokazu
Published in British journal of pharmacology (01.07.2003)
Published in British journal of pharmacology (01.07.2003)
Get full text
Journal Article